Supplementation of n3 Long-chain Polyunsaturated Fatty Acid Synergistically Decreases Insulin Resistance with Weight Loss of Obese Prepubertal and Pubertal Children

Archives of Medical Research

Volumn 42, Issue 6, 2011, Pages 502-508

  López Alarcón, Mardia ^a   Martínez Coronado, Araceli ^a   Velarde Castro, Oscar ^a   Rendón Macías, Enrique ^a   Fernández, José ^b  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adiponectin; Inflammation; Insulin resistance; N3 fatty acids; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INSULIN; LEPTIN; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; OBESITY; PATIENT COMPLIANCE; PREPUBERTY; PUBERTY; SALMON; SCHOOL CHILD; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; CHILD; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; PLACEBOS; PUBERTY; QUESTIONNAIRES; WEIGHT LOSS;

EID: 82855171050     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.06.010     Document Type: Article

References (46)

1. Popkin B.M., Gordon-Larsen P. The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord 2004, 28:S2-S9.
2. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
3. Shama-Levy T., Villalpando-Hernández S., Rivera-Dommarco J.A. Resultados de Nutrición de la ENSANUT 2006 2007, Instituto Nacional de Salud Pública, Cuernavaca, México.
4. Weiss R., Kaufman F.R. Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 2008, 31:S310-S316.
5. Chiarelli F., Marcovecchio M.L. Insulin resistance and obesity in childhood. Eur J Endocrinol 2008, 159:S67-S74.
6. Levy-Marchal C., Arslanian S., Cutfield W., et al. Insulin resistance in children: consensus, perspective and future directions. J Clin Endocrinol Metab 2010, 95:5189-5198. ESPE-LWPES-ISPAD-APPES-APEG-SLEP-JSPE; Insulin Resistance in Children Consensus Conference Group.
7. Visser M., Bouter L.M., McQuillan G.M., et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
8. Maachi M., Pieroni L., Bruckert E., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFα, leptin and IL-6 levels in obese women. Int J Obes 2004, 28:993-997.
9. Chen J., Wildman R.P., Hamm L.L., et al. Association between inflammation and insulin resistance in U.S. nondiabetic adults. Diabetes Care 2004, 27:2960-2965.
10. Bastard J.P., Jardel C., Bruckert E., et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese womenafter weight loss. J Clin Endocrinol Metab 2000, 85:3338-3342.
11. Ziemke F., Mantzoros C.S. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010, 91:S258-S261.
12. Hotamisligil G.S., Budavari A., Murray D., et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes; central role of tumor necrosis factor-α. J Clin Invest 1994, 94:1543-1549.
13. Greenberg A.S., Nordan R.P., McIntosh J., et al. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 1992, 52:4113-4116.
14. Giugliano G., Nicoletti G., Grella E., et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 2004, 57:190-194.
15. Compher C., Badellino K.O. Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008, 32:645-647.
16. Blok W.L., Katan M.B., van der Meer J.W.M. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996, 126:1515-1533.
17. Calder P.C. N-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997, 41:203-234.
18. Caughey G.E., Mantzioris E., Gibson R.A., et al. The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996, 63:116-122.
19. Reis C.E., Bressan J., Alfenas R.C. Effect of the diet components on adiponectin levels. Nutr Hosp 2010, 25:881-888.
20. Kondo K., Morino K., Nishio Y., et al. Effects of a fish-based diet on the serum adiponectin concentration in young, non-obese, healthy Japanese subjects. J Atheroscler Thromb 2010, 17:628-637.
21. González-Périz A., Horrillo R., Ferré N., et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2010, 23:1946-1957.
22. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (2002/2005). Available at: http://www.nap.edu/catalog/10490.html.
23. Berber A., Gómez-Santos R., Fanghänel G., et al. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dislipidemias in Mexican population. Int J Obesity 2001, 25:1794-1799.
24. Keskin M., Kurtoglu S., Kendirci M., et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005, 115:e500-e503.
25. García Cuartero B., García Lacalle C., Jiménez Lobo C., et al. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children. An Pediatr (Barc) 2007, 66:481-490.
26. Mori Y., Murakawa Y., Katoh S., et al. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus. Metabolism 1997, 46:1458-1464.
27. Ghafoorunissa, Ibrahim A., Natarajan S. Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta 2005, 1733:67-75.
28. Taouis M., Dagou C., Ster C., et al. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle. Am J Physiol Endocrinol Metab 2002, 282:E664-E671.
29. Kabagambe E.K., Tsai M.Y., Hopkins P.N., et al. Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 2008, 54:154-162.
30. Browning L.M. N-3 polyunsaturated fatty acids, inflammation and obesity-related disease. Proc Nutr Soc 2003, 62:447-453.
31. Hendrich S. (n-3) Fatty acids: clinical trials in people with type 2 diabetes. Adv Nutr 2010, 1:3-7.
32. Burrows T., Collins C.E., Garg M.L. Omega-3 index, obesity and insulin resistance in children. Int J Pediatr Obes 2011, (Epub ahead of print).
33. Couet C., Delarue P., Autoine J.M., et al. Effect of dietary fish oil on body mass and basal fat oxidation in healthy adults. J Obes 1997, 21:637-643.
34. Noreen E.E., Sass M.J., Crowe M.L., et al. Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. J Int Soc Sports Nutr 2010, 7:31.
35. Kunesova M., Braunerova R., Plavaty P., et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 2006, 55:63-72.
36. Krebs J.D., Browning L.M., McLean N.K., et al. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinemic women. Int J Obes 2006, 30:1534-1544.
37. Sesti G., Folli F., Perego L., et al. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One 2011 Mar 8, 6:e17737.
38. Ramel A., Martinéz A., Kiely M., et al. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008, 51:1261-1268.
39. Krebs J.D., Browning L.M., McLean N.K., et al. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes 2006, 30:1535-1544.
40. Kratz M., Swarbrick M.M., Callahan H.S., et al. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008, 87:347-353.
41. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009, 139:804S-819S.
42. Gibney M.J., Hunter B. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993, 47:255-259.
43. Mebarek S., Ermak N., Benzaria A., et al. Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis. Br J Nutr 2009, 101:852-858.
44. Deshmukh-Taskar P.R., O'Neil C.E., Nicklas T.A., et al. Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr 2009, 12:2493-2503.
45. Sun G., Vasdev S., Martin G.R., et al. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and β-cell function in the Newfoundland population. Diabetes 2005, 54:3336-3339.
46. Song Y., Buring J.E., Manson J.E., et al. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes mellitus. Diabetes Care 2004, 27:59-65.